NDLI: CDK/CCN and CDKI Alterations for Cancer Prognosis and Therapeutic Predictivity

Content Provider	PubMed Central
Author	Bonelli, Patrizia Tuccillo, Franca Maria Borrelli, Antonella Schiattarella, Antonietta Buonaguro, Franco Maria
Copyright Year	2014
Abstract	The regulation of cell growth and division occurs in an accurate sequential manner. It is dictated by the accumulation of cyclins (CCNs) and cyclin-dependent kinases (CDKs) complexes and degradation of CCNs. In human tumors, instead, the cell cycle is deregulated, causing absence of differentiation and aberrant cell growth. Oncogenic alterations of CCNs, CDKs, and CDKIs have been reported in more than 90% of human cancers, and the most frequent are those related to the G1 phase. Several molecular mechanisms, including gene overexpression, chromosomal translocations, point mutations, insertions and deletions, missense and frame shift mutation, splicing, or methylation, may be responsible for these alterations. The cell cycle regulators are involved in tumor progression given their association with cancers characterized by higher incidence of relapses and chemotherapy resistance. In the last decade anticancer drug researches focused on new compounds, able to target molecules related to changes in genes associated with tumor status. Recently, the studies have focused on the restoration of cell cycle control modulating molecular targets involved in cancer-cell alterations. This paper aims to correlate alterations of cell cycle regulators with human cancers and therapeutic responsivity.
Related Links	http://dx.doi.org/10.1155/2014/361020
Starting Page	361020
File Format	PDF
ISSN	23146133
e-ISSN	23146141
Journal	BioMed Research International
Volume Number	2014
Language	English
Publisher	Hindawi Publishing Corporation
Publisher Date	2014-01-01
Access Restriction	Open
Rights Holder	Hindawi Publishing Corporation
Subject Keyword	Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Immunology and Microbiology Medicine Biochemistry, Genetics and Molecular Biology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Metabolic Alterations of Thyroid Cancer as Potential Therapeutic Targets

The p57 CDKi integrates stress signals into cell-cycle progression to promote cell survival upon stress

Novel Tools for Prostate Cancer Prognosis, Diagnosis, and Follow-Up

Identification of Cdk targets that control cytokinesis

The IQGAP Iqg1 is a regulatory target of CDK for cytokinesis in Candida albicans

Prognosis Relevance of Serum Cytokines in Pancreatic Cancer

A CDK-catalysed regulatory phosphorylation for formation of the DNA replication complex Sld2–Dpb11

Emerging Therapeutic Biomarkers in Endometrial Cancer

Crystal structure of a γ-herpesvirus cyclin–cdk complex

CDK/CCN and CDKI Alterations for Cancer Prognosis and Therapeutic Predictivity

Similar Documents

Metabolic Alterations of Thyroid Cancer as Potential Therapeutic Targets

The p57 CDKi integrates stress signals into cell-cycle progression to promote cell survival upon stress

Novel Tools for Prostate Cancer Prognosis, Diagnosis, and Follow-Up

Identification of Cdk targets that control cytokinesis

The IQGAP Iqg1 is a regulatory target of CDK for cytokinesis in Candida albicans

Prognosis Relevance of Serum Cytokines in Pancreatic Cancer

A CDK-catalysed regulatory phosphorylation for formation of the DNA replication complex Sld2–Dpb11

Emerging Therapeutic Biomarkers in Endometrial Cancer

Crystal structure of a γ-herpesvirus cyclin–cdk complex

CDK/CCN and CDKI Alterations for Cancer Prognosis and Therapeutic Predictivity